Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Pharmacology, Toxicology and Pharmaceutical Science
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
81%
Adverse Drug Reaction
10%
Antidepressant
16%
Antihypertensive Agent
13%
Antipsychotic
11%
Bioavailability
10%
Biological Marker
6%
Calcium Channel
6%
Calcium Channel Blocker
6%
Clinical Pharmacology
14%
Clinical Study
6%
Clozapine
25%
Clozapine N Oxide
15%
CYP2D6
17%
Cytochrome P450
15%
Decanoic Acid
12%
Degenerative Disease
6%
Desmethylclozapine
10%
Diseases
29%
Dopamine Receptor Stimulating Agent
6%
Drug Administration
10%
Drug Development
14%
Drug Interaction
27%
Elimination
13%
Fluoxetine
20%
Fluvoxamine
7%
Glucuronide
6%
Haloperidol Decanoate
13%
Hypertension
12%
Ketoconazole
12%
Kidney Failure
12%
Maturity Onset Diabetes of the Young
11%
Midazolam
12%
Monotherapy
8%
Normal Human
9%
Paroxetine
10%
Pathophysiology
12%
Pharmacodynamics
48%
Pharmacogenomics
69%
Pharmacokinetic Parameter
7%
Pharmacokinetics
100%
Pharmacotherapy
48%
Prostate Cancer
6%
Psychotropic Agent
25%
Reduced Haloperidol
72%
Schizophrenia
12%
Selective Serotonin Reuptake Inhibitor
8%
Sertraline
7%
Sustained Release
9%
Zofran
6%
Medicine and Dentistry
Cancer Incidence
6%
Chronic Liver Disease
6%
Clinical Decision Making
9%
Controlled Clinical Trial
9%
Cost Benefit Analysis
5%
Diseases
6%
Drug Therapy
35%
Education
6%
Ethnic Difference
6%
Genetics
32%
Glycon
12%
Health Care Cost
7%
Hepatocellular Carcinoma
6%
Human Genome
10%
Maturity Onset Diabetes of the Young
12%
Mental Disorder
6%
Nervous System Disorder
6%
Neurodevelopmental Disorder
12%
Neurologic Disease
12%
Personalized Medicine
25%
Pharmacogenetic Testing
9%
Pharmacogenomics
44%
Prostate Cancer
6%
Translating (Language)
22%
Treatment Response
9%
Neuroscience
5-HT2C Receptor
9%
Antipsychotic
9%
Blood Brain Barrier
9%
Blood Plasma
8%
Clinical Decision Making
6%
Clozapine
6%
Cytochrome P450
9%
Cytochrome P450 2C19
9%
Cytochrome P450 2D6
15%
Dopamine Agonist
6%
Drug Interaction
6%
Drug Therapy
40%
Enzymes
10%
Genetics
40%
Gepirone
6%
L-DOPA
6%
Mental Disorder
31%
Metabolic Pathway
7%
Nervous System Disorder
6%
Oxide
6%
Personalized Medicine
18%
Precision Medicine
6%
Psychiatry
9%
Psychoactive Drug
22%
Selective Serotonin Reuptake Inhibitor
6%
Serotonergic System
9%
